Stock & Company Details
GH Research PLC $GHRS
Price:
N/A
N/A
69M
$2B
52 Week High:
N/A
10 Day Average Volume:
N/A
-31.58
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Services
GHRS technical indicators
Latest GH Research PLC (GHRS) indicator readings as of 2026-09-18.
GHRS's 14-day RSI is 51.5, in neutral territory. At $28.26 it is trading 38.3% above its 200-day moving average of $20.43, and below its 50-day average of $28.29. Price sits in the middle of its Bollinger Bands ($26.86 to $29.09). ADX reads 18.7, indicating a range-bound market rather than a trend.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. Its focus is on developing novel and proprietary 5-Methoxy-N,N-Dimethyltryptamine, or 5-MeO-DMT, therapies for the treatment of patients with Treatment-Resistant Depression, or TRD.
Finance Bot
Ask your questions
Start by typing a question below.
